In presence of such morphology, the immunoreactivity for general neuroendocrine markers (preferentially chromogranin A, and when chromogranin A is negative, diffuse positivity for synaptophysin and INSM1) is diagnostic for LCNEC. Here, CHGA is linked to large cell neuroendocrine carcinoma.